Oncology
Rheumatology
Neurology
Other Products
Ruxolitinib
Ruxolitinib is indicated for the treatment of non-segmental vitiligo with facial involvement, and mild to moderate atopic dermatitis (eczema).
Curious about job opportunities?
Business Development
Careers
About Us
Our Story
Contact
Blog